0001104659-22-129514.txt : 20221222 0001104659-22-129514.hdr.sgml : 20221222 20221222160536 ACCESSION NUMBER: 0001104659-22-129514 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221222 FILED AS OF DATE: 20221222 DATE AS OF CHANGE: 20221222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pisano Wayne CENTRAL INDEX KEY: 0001743611 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32587 FILM NUMBER: 221482005 MAIL ADDRESS: STREET 1: C/O PROVENTION BIO, INC. STREET 2: P.O. BOX 666 CITY: OLDWICK STATE: NJ ZIP: 08858 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Altimmune, Inc. CENTRAL INDEX KEY: 0001326190 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202726770 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 910 CLOPPER ROAD STREET 2: SUITE 201S CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 2406541450 MAIL ADDRESS: STREET 1: 910 CLOPPER ROAD STREET 2: SUITE 201S CITY: GAITHERSBURG STATE: MD ZIP: 20878 FORMER COMPANY: FORMER CONFORMED NAME: PHARMATHENE, INC DATE OF NAME CHANGE: 20071016 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHCARE ACQUISITION CORP DATE OF NAME CHANGE: 20050505 4 1 tm2233389-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-12-22 0 0001326190 Altimmune, Inc. ALT 0001743611 Pisano Wayne C/O ALTIMMUNE, INC., 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 1 0 0 0 Common Stock, par value $0.0001 2022-12-22 4 M 0 20000 2.60 A 28498 D Common Stock, par value $0.0001 2022-12-22 4 S 0 20000 15.0134 D 8498 D Stock Options (option to buy) 2.60 2022-12-22 4 M 0 20000 0.00 D 2029-01-02 Common Stock, par value $0.0001 20000 0 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.0000 to $15.0900, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The option became vested and exercisable in two equal installments on February 28, 2019 and August 30, 2019, in each case, generally subject to the reporting person's continued service through the applicable vesting date. /s/ Richard Eisenstadt, as Attorney-in-Fact 2022-12-22